Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thanks for joining us at the Bank of America Health Care Conference. I'm Tazeen Ahmad, one of the senior biotech analysts here at the firm. It is my pleasure this morning to introduce our next presenting company, Alnylam. Speaking for Alnylam this morning is Chief Executive Officer, John Maraganore. John, good morning.
Good morning, Tazeen. And good morning, everybody, on the call.
So we're going to be spending the next 30 minutes talking about all the exciting things happening at Alnylam. But maybe as a starter for anyone on the phone who may not be as familiar with your company, can you just give us a quick overview of the platform of Alnylam, some of your recent accomplishments? And we can go into some details of upcoming catalysts, if that works, John.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |